Butterfly Medical Advances Minimally Invasive BPH Technology With $21M
BOSTON and YOKNEAM, Israel, May 14, 2026 Butterfly Medical announced the successful completion of an upsized $21 million Series...
Series C Funding
Advertisement
Iterative Health Secures $77M to Accelerate Clinical Trials
CAMBRIDGE, Massachusetts, April 2026 Iterative Health announced the successful close of a $77 million Series C funding round, reinforcing...
Aspen Neuroscience Secures $115M to Advance Cell Therapy
SAN DIEGO, CA — November 20, 2025 — Aspen Neuroscience, a leading developer of personalized autologous cell therapies for...
Tubulis Secures €344 M Series C to Accelerate ADC Clinical Growth
Munich, Germany, October 30, 2025 — Tubulis GmbH announced the successful second and final closing of its Series C...
Advertisement
